Pulmonx Corporation LUNG
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 26.18% | -30.97% | 25.31% | 8.01% | -5.02% |
| Total Depreciation and Amortization | 85.00% | -63.75% | 126.71% | -51.17% | 7.55% |
| Total Amortization of Deferred Charges | -11.64% | 271.76% | -174.56% | 776.92% | 18.18% |
| Total Other Non-Cash Items | -12.57% | 1.95% | -15.66% | -9.91% | 9.90% |
| Change in Net Operating Assets | 116.35% | 6.13% | -1,213.28% | -102.74% | 197.57% |
| Cash from Operations | 48.36% | -42.53% | 13.21% | -108.85% | 70.44% |
| Capital Expenditure | 88.89% | 30.77% | 85.39% | -81.63% | 83.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 59.42% | -66.78% |
| Cash from Investing | 88.89% | 30.77% | -100.15% | 59.22% | -66.46% |
| Total Debt Issued | -100.00% | -- | -- | -- | -- |
| Total Debt Repaid | 99.86% | -72,449.02% | -5,000.00% | 97.92% | -- |
| Issuance of Common Stock | -100.00% | 127.36% | -48.29% | 632.14% | -95.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 51.06% | -- |
| Cash from Financing | -125.32% | 3,583.64% | -69.61% | 370.15% | -110.09% |
| Foreign Exchange rate Adjustments | 101.00% | -141.49% | -32.11% | 160.89% | -455.24% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.99% | -20.28% | -726.82% | 18.84% | -74.99% |